EMG
KERX

Ellington Management Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Ellington Management Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40,900
Closed -$697K – 753
2014
Q1 		$697K Buy
+40,900
New +$697K 0.2% 125